tyrosine has been researched along with Scleroderma, Systemic in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (28.57) | 18.7374 |
1990's | 1 (7.14) | 18.2507 |
2000's | 5 (35.71) | 29.6817 |
2010's | 3 (21.43) | 24.3611 |
2020's | 1 (7.14) | 2.80 |
Authors | Studies |
---|---|
Beckmann, D; Boin, F; Bottini, N; Hansen, U; Holmes, ZJ; Kumar, GS; Lee, MC; Mikulski, Z; Page, R; Peti, W; Sacchetti, C; Santelli, E; Wen, Y; Yang, S; Zhang, R; Zoccheddu, M | 1 |
Batteux, F; Bei, Y; Chéreau, C; Dinh-Xuan, AT; Duong-Quy, S; Hua-Huy, T; Le-Dong, NN; Nicco, C; Tiev, KP | 1 |
Fujimoto, M; Hamaguchi, Y; Hasegawa, M; Ishiura, N; Komura, K; Kumada, S; Matsushita, T; Odaka, M; Sato, S; Takehara, K | 1 |
Batteux, F; Chéreau, C; Dinh-Xuan, AT; Hua-Huy, T; Kavian, N; Marut, W; Nicco, C; Servettaz, A; Weill, B | 1 |
AKISAWA, J | 1 |
Chiang, TM; Postlethwaite, AE | 3 |
Black, CM; Denton, CP; Frost, MT; Kingdon, EJ; Mani, AR; Moore, KP; Powis, SH | 1 |
Boyle, AJ; Keech, MK; McCann, DS; Mitchell, JG | 1 |
Cotton, SA; Freemont, AJ; Herrick, AL; Jayson, MI | 1 |
Fujimoto, M; Hamaguchi, Y; Hasegawa, M; Kaburagi, Y; Komura, K; Nagaoka, T; Saito, E; Sato, S; Takehara, K; Tedder, TF | 1 |
Bashey, RI; Jimenez, SA; McArthur, WM; Rosenbloom, J | 1 |
Jones, JD; Ulrich, JA; Winkelmann, RK | 1 |
14 other study(ies) available for tyrosine and Scleroderma, Systemic
Article | Year |
---|---|
Oxidative stress promotes fibrosis in systemic sclerosis through stabilization of a kinase-phosphatase complex.
Topics: Fibroblasts; Fibrosis; Humans; Oxidative Stress; Scleroderma, Systemic; Tyrosine | 2022 |
RhoA/Rho-kinase activation promotes lung fibrosis in an animal model of systemic sclerosis.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Actins; Animals; Disease Models, Animal; Female; Hypochlorous Acid; Lung; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Pneumonia; Pulmonary Fibrosis; rho-Associated Kinases; Scleroderma, Systemic; Skin; Smad2 Protein; Smad3 Protein; Tyrosine | 2016 |
Autoantibody-mediated regulation of B cell responses by functional anti-CD22 autoantibodies in patients with systemic sclerosis.
Topics: Adult; Animals; Autoantibodies; B-Lymphocytes; Blotting, Western; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Phosphorylation; Protein-Tyrosine Kinases; Scleroderma, Systemic; Sialic Acid Binding Ig-like Lectin 2; Tyrosine | 2010 |
Amelioration of systemic fibrosis in mice by angiotensin II receptor blockade.
Topics: Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Animals; Biomarkers; Biphenyl Compounds; Breath Tests; Disease Models, Animal; Female; Fibrosis; Hypochlorous Acid; Injections, Intradermal; Irbesartan; Lung; Mice; Mice, Inbred BALB C; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidants; Pulmonary Fibrosis; Scleroderma, Systemic; Skin; Tetrazoles; Tyrosine | 2013 |
[CLINICAL STUDIES ON THE INTERMEDIARY METABOLISM OF TYROSINE. 3. URINARY EXCRETION ON INTERMEDIARY METABOLITES OF TYROSINE IN PATIENTS WITH SOME ENDOCRINE DISEASES AND THE RELATED DISORDERS].
Topics: Addison Disease; Biomedical Research; Diabetes Mellitus; Endocrine System Diseases; Humans; Hypercholesterolemia; Hypoparathyroidism; Lactates; Obesity; Phenylpyruvic Acids; Proteins; Scleroderma, Systemic; Thyroid Diseases; Tyrosine; Urine | 1964 |
Increase in phosphotidylinositide-3 kinase activity by nitrotyrosylation of lysates of platelets from patients with systemic sclerosis.
Topics: Adult; Blood Platelets; Case-Control Studies; Cell-Free System; Class II Phosphatidylinositol 3-Kinases; Female; Humans; Kinetics; Male; Middle Aged; Phosphatidylinositol 3-Kinases; Protein Processing, Post-Translational; Scleroderma, Systemic; Tyrosine | 2006 |
Low plasma protein nitrotyrosine levels distinguish primary Raynaud's phenomenon from scleroderma.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Biomarkers; Blood Proteins; Chromatography, Gas; Diagnosis, Differential; Female; Humans; Male; Middle Aged; Raynaud Disease; Scleroderma, Systemic; Tyrosine | 2006 |
A cell model system to study regulation of phosphotidylinositol 3-kinase and protein kinase B activity by cytokines/growth factors produced by type I collagen stimulated immune cells from patients with systemic sclerosis.
Topics: Arthritis, Rheumatoid; Case-Control Studies; Cell Line; Cells, Cultured; Collagen Type I; Culture Media; Cytokines; Enzyme-Linked Immunosorbent Assay; Humans; Intercellular Signaling Peptides and Proteins; Leukocytes, Mononuclear; Lupus Erythematosus, Systemic; Megakaryocytes; Nitric Oxide Synthase; Osteoarthritis; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Scleroderma, Systemic; Tyrosine | 2007 |
Alteration in protein kinase B (AKT) activity in platelets from patients with systemic sclerosis.
Topics: Blood Platelets; Case-Control Studies; Humans; Immunoblotting; Immunoprecipitation; Models, Biological; Nitrogen; Phosphatidylinositol 3-Kinases; Platelet Activation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Scleroderma, Systemic; Signal Transduction; Tyrosine | 2008 |
Tyrosine metabolism in connective tissue disease. P-hydroxyphenylpyruvic acid excretion.
Topics: Arthritis, Rheumatoid; Collagen Diseases; Connective Tissue; Glucuronates; Humans; Liver Diseases; Lupus Erythematosus, Systemic; Phenylpyruvic Acids; Scleroderma, Systemic; Spectrum Analysis; Tyrosine | 1967 |
Endothelial expression of nitric oxide synthases and nitrotyrosine in systemic sclerosis skin.
Topics: Endothelium, Vascular; Humans; Immunoenzyme Techniques; Microcirculation; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Scleroderma, Systemic; Severity of Illness Index; Skin; Tyrosine | 1999 |
CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse.
Topics: ADP-ribosyl Cyclase; ADP-ribosyl Cyclase 1; Animals; Antigens, CD; Antigens, CD19; Antigens, Differentiation; B-Lymphocytes; Blotting, Western; Calcium; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Fibrosis; Flow Cytometry; Humans; Hydroxyproline; Immunoglobulin M; Interleukin-6; Membrane Glycoproteins; Mice; NAD+ Nucleosidase; Phosphorylation; Precipitin Tests; Scleroderma, Systemic; Signal Transduction; Skin; Time Factors; Tyrosine; Up-Regulation | 2002 |
Selective inhibition of excessive scleroderma fibroblast collagen production by lymphokines from normal human mononuclear cells.
Topics: Adult; Aged; Cell Line; Collagen; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Female; Fibroblasts; Fucose; Humans; Lymphokines; Male; Middle Aged; Scleroderma, Systemic; Skin; Tyrosine | 1985 |
Urinary amino acid excretion in patients with scleroderma.
Topics: Arginine; Aspartic Acid; Chelating Agents; Female; Glutamates; Histidine; Humans; Isoleucine; Leucine; Lysine; Male; Methionine; Phenylalanine; Renal Aminoacidurias; Scleroderma, Systemic; Threonine; Tyrosine; Valine | 1971 |